ACS Medicinal Chemistry Letters · 2013 · 30 citations · 13 references
MedicineMedicinal ChemistryPharmacologyAntimicrobial PharmacologyAntimicrobial ResistanceDrug DiscoveryAntibacterial AgentsAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceAntibacterial Drug DevelopmentAntimicrobial Drug DevelopmentCytochrome P450 InhibitionHeteroaromatic CompoundsMonoamine OxidasesNovel Antibacterial AgentsNovel Antibacterial Drug DiscoveryOxazolidinone Antibiotics
Novel oxazolidinone analogues bearing a condensed heteroaromatic ring as the C-ring substructure were synthesized as candidate antibacterial agents. Analogues 16 and 21 bearing imidazo[1,2-a]pyridine and 18 and 23 bearing [1,2,4]triazolo[1,5-a]pyridine as the C-ring had excellent in vitro antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus faecalis (VRE), and penicillin-resistant Streptococcus pneumoniae (PRSP). They also showed promising therapeutic effects in a mouse model of lethal infection. Preliminary safety data (inhibitory effects on cytochrome P450 isoforms and monoamine oxidases) were satisfactory. Further evaluation of 18 and 23 is ongoing.
13
Seok‐Ming Toh, Liqun Xiong, César A. Arias et al. · Molecular Microbiology · 2007 · 335 citations · Full text
Folkert Reck, Fei Zhou, Marc Girardot et al. · Journal of Medicinal Chemistry · 2005 · 326 citations · Full text
Oxazolidinone Antibacterial Agents
Steven J. Brickner · Current Pharmaceutical Design · 1996 · 169 citations